Brandinium

Trademark search for:

NEURALTUS PHARMACEUTICALS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2009-02-10 — Application filed
  • 2009-02-13 — Application filed
  • 2009-02-13 — Application filed
  • 2009-04-30 — Assigned to examiner
  • 2009-05-01 — Final disposition recorded
  • 2009-05-01 — Final disposition recorded
  • 2009-05-01 — Final disposition recorded
  • 2009-05-13 — Automatic update of assignment of ownership
  • 2009-08-20 — Examiners amendment -written
  • 2009-08-20 — Approved for pub - principal register
  • 2009-08-20 — Examiners amendment e-mailed
  • 2009-08-20 — Notification of examiners amendment e-mailed
  • 2009-08-20 — Examiner's amendment entered
  • 2009-08-25 — Assigned to lie
  • 2009-08-25 — Law office publication review completed
  • 2009-09-09 — Notice of publication
  • 2009-09-29 — Published for opposition
  • 2009-12-22 — Noa mailed - sou required from applicant
  • 2010-06-21 — Sou teas extension received
  • 2010-06-21 — Sou extension 1 filed
  • 2010-07-19 — Case assigned to intent to use paralegal
  • 2010-07-19 — Sou extension 1 granted
  • 2010-07-20 — Notice of approval of extension request e-mailed
  • 2010-12-13 — Sou teas extension received
  • 2010-12-13 — Sou extension 2 filed
  • 2010-12-16 — Sou extension 2 granted
  • 2010-12-17 — Notice of approval of extension request e-mailed
  • 2011-04-08 — Teas statement of use received
  • 2011-04-08 — Use amendment filed
  • 2011-04-11 — Statement of use processing complete
  • 2011-04-13 — Allowed principal register - sou accepted
  • 2011-04-13 — Assigned to lie
  • 2011-04-14 — Law office registration review completed
  • 2011-04-15 — Notice of acceptance of statement of use e-mailed
  • 2011-05-17 — Registered-principal register
  • 2015-03-11 — Teas change of owner address received
  • 2015-03-11 — Applicant/correspondence changes (non-responsive) entered
  • 2016-05-17 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2016-06-14 — Teas change of owner address received
  • 2016-06-14 — Applicant/correspondence changes (non-responsive) entered
  • 2016-10-14 — Teas section 8 & 15 received
  • 2016-12-22 — Case assigned to post registration paralegal
  • 2016-12-23 — Post registration action mailed - sec. 8 & 15
  • 2017-04-20 — Office action issued
  • 2017-04-24 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  • 2017-04-24 — Notice of acceptance of sec. 8 & 15 - e-mailed
  • 2020-05-17 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2021-11-19 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2021-11-19 — Final status recorded

Owner Information

NEURALTUS PHARMACEUTICALS, INC.
San Bruno , CA
NEURALTUS PHARMACEUTICALS, INC.
Palo Alto , CA
NEURALTUS PHARMACEUTICALS, INC.
MENLO PARK , CA
Taiji BioMedical, Inc.
Menlo Park , CA

Correspondent

Matthew J. Kuykendall WILSON SONSINI GOODRICH & ROSATI
650 PAGE MILL RD
PALO ALTO, CA 94304-1050
UNITED STATES

Filing Details

Filing Date:
2009-02-10
Status Date:
2021-11-19
Category:
Pharmaceuticals
Filing Year:
2009

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.